CHAOJU EYE CARE Reports Annual Results with Net Profit Attributable to Owners of RMB 1.83 Billion, Down 5.96% Year-on-Year

Stock News

03/31

CHAOJU EYE CARE (02219) announced its annual results for the period ending December 31, 2025. The Group recorded revenue of RMB 13.6 billion, a decrease of 3.21% compared to the previous year. Profit attributable to owners of the parent company was RMB 1.83 billion, representing a decline of 5.96% year-on-year. Earnings per share were RMB 0.26. The Board has proposed a final dividend of HK$0.2423 per share.

The Group's revenue from consumer ophthalmic services decreased by 2.4% to RMB 6.9 billion for the year ending December 31, 2025, down from RMB 7.06 billion for the year ending December 31, 2024. This was primarily attributed to pricing adjustments implemented in response to intensified market competition, particularly in refractive surgery services.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1146765491"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1146765491\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1146765491?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-31 17:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146765491","market":"nz","top_or_hot":-1,"title":"CHAOJU EYE CARE Reports Annual Results with Net Profit Attributable to Owners of RMB 1.83 Billion, Down 5.96% Year-on-Year","media":"Stock News","content":"<p>CHAOJU EYE CARE (02219) announced its annual results for the period ending December 31, 2025. The Group recorded revenue of RMB 13.6 billion, a decrease of 3.21% compared to the previous year. Profit attributable to owners of the parent company was RMB 1.83 billion, representing a decline of 5.96% year-on-year. Earnings per share were RMB 0.26. The Board has proposed a final dividend of HK$0.2423 per share.</p>\n<p>The Group's revenue from consumer ophthalmic services decreased by 2.4% to RMB 6.9 billion for the year ending December 31, 2025, down from RMB 7.06 billion for the year ending December 31, 2024. This was primarily attributed to pricing adjustments implemented in response to intensified market competition, particularly in refractive surgery services.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CHAOJU EYE CARE Reports Annual Results with Net Profit Attributable to Owners of RMB 1.83 Billion, Down 5.96% Year-on-Year</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCHAOJU EYE CARE Reports Annual Results with Net Profit Attributable to Owners of RMB 1.83 Billion, Down 5.96% Year-on-Year\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-31 17:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CHAOJU EYE CARE (02219) announced its annual results for the period ending December 31, 2025. The Group recorded revenue of RMB 13.6 billion, a decrease of 3.21% compared to the previous year. Profit attributable to owners of the parent company was RMB 1.83 billion, representing a decline of 5.96% year-on-year. Earnings per share were RMB 0.26. The Board has proposed a final dividend of HK$0.2423 per share.</p>\n<p>The Group's revenue from consumer ophthalmic services decreased by 2.4% to RMB 6.9 billion for the year ending December 31, 2025, down from RMB 7.06 billion for the year ending December 31, 2024. This was primarily attributed to pricing adjustments implemented in response to intensified market competition, particularly in refractive surgery services.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1209","symbol_name":"保健护理机构","start_time":0,"source_url":"","article_id":"1146765491","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146765491","pubTimestamp":1774949785,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"CHAOJU EYE CARE (02219) announced its annual results for the period ending December 31, 2025. The Group recorded revenue of RMB 13.6 billion, a decrease of 3.21% compared to the previous year. Profit...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1209":"保健护理机构","BK1587":"次新股","02219":"朝聚眼科"},"translate_title":"朝聚眼科公布全年业绩归属于所有者净利润18.3亿元同比下降5.96%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02219":1},"content_text":"CHAOJU EYE CARE (02219) announced its annual results for the period ending December 31, 2025. The Group recorded revenue of RMB 13.6 billion, a decrease of 3.21% compared to the previous year. Profit attributable to owners of the parent company was RMB 1.83 billion, representing a decline of 5.96% year-on-year. Earnings per share were RMB 0.26. The Board has proposed a final dividend of HK$0.2423 per share.\nThe Group's revenue from consumer ophthalmic services decreased by 2.4% to RMB 6.9 billion for the year ending December 31, 2025, down from RMB 7.06 billion for the year ending December 31, 2024. This was primarily attributed to pricing adjustments implemented in response to intensified market competition, particularly in refractive surgery services.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}